Hyaluronan Synthase 3 Null Mice Exhibit Decreased Intestinal Inflammation and Tissue Damage in the DSS-Induced Colitis Model

International Journal of Cell Biology

Volumn 2015, Issue , 2015, Pages

  Kessler, Sean P ^a   Obery, Dana R ^a   De La Motte, Carol ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEXTRAN SULFATE; HYALURONAN SYNTHASE 1; HYALURONAN SYNTHASE 3; INTERLEUKIN 6; SYNTHETASE; UNCLASSIFIED DRUG;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COLON; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE ACTIVITY SCORE; DISEASE COURSE; ENTERITIS; ENZYME ACTIVITY; EXPERIMENTAL COLITIS; IMMUNOHISTOCHEMISTRY; LAMINA PROPRIA; LEUKOCYTE; MICROVASCULATURE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECTUM HEMORRHAGE; RECTUM PROLAPSE; TISSUE INJURY; WEIGHT REDUCTION;

EID: 84942274951     PISSN: 16878876     EISSN: 16878884     Source Type: Journal    
DOI: 10.1155/2015/745237     Document Type: Article

References (54)

1. A. J. Day and J. K. Sheehan, "Hyaluronan: polysaccharide chaos to protein organisation," Current Opinion in Structural Biology, vol. 11, no. 5, pp. 617-622, 2001.
2. P. H. Weigel, V. C. Hascall, and M. Tammi, "Hyaluronan synthases," The Journal of Biological Chemistry, vol. 272, no. 22, pp. 13997-14000, 1997.
3. T. D. Camenisch, A. P. Spicer, T. Brehm-Gibson et al., "Disruption of hyaluronan synthase-2 abrogates normal cardiac morphogenesis and hyaluronan-mediated transformation of epithelium to mesenchyme," The Journal of Clinical Investigation, vol. 106, no. 3, pp. 349-360, 2000.
4. A. M. Arranz, K. L. Perkins, F. Irie et al., "Hyaluronan deficiency due to Has3 knock-out causes altered neuronal activity and seizures via reduction in brain extracellular space," The Journal of Neuroscience, vol. 34, no. 18, pp. 6164-6176, 2014.
5. J. A. MacK, R. J. Feldman, N. Itano et al., "Enhanced inflammation and accelerated wound closure following tetraphorbol ester application or full-thickness wounding in mice lacking hyaluronan synthases Has1 and Has3," The Journal of Investigative Dermatology, vol. 132, no. 1, pp. 198-207, 2012.
6. Y. Wang, M. E. Lauer, S. Anand , J. A. Mack, and E. V. Maytin, "Hyaluronan synthase 2 protects skin fibroblasts against apoptosis induced by environmental stress," Journal of Biological Chemistry, vol. 289, no. 46, pp. 32253-32265, 2014.
7. J. G. Hollyfield, M. E. Rayborn, M. Tammi, and R. Tammi, "Hyaluronan in the interphotoreceptor matrix of the eye: species differences in content, distribution, ligand binding and degradation," Experimental Eye Research, vol. 66, no. 2, pp. 241-248, 1998.
8. J. R. Fraser and T. C. Laurent, "Turnover and metabolism of hyaluronan," Ciba Foundation Symposium, vol. 143, pp. 41-53, 1989.
9. D. R. Michael, A. O. Phillips, A. Krupa et al., "The human hyaluronan synthase 2 (HAS2) gene and its natural antisense RNA exhibit coordinated expression in the renal proximal tubular epithelial cell," The Journal of Biological Chemistry, vol. 286, no. 22, pp. 19523-19532, 2011.
10. C. A. de laMotte, V. C.Hascall, J. Drazba, S. K. Bandyopadhyay, and S. A. Strong, Mononuclear leukocytes bind to specific hyaluronan structures on colon mucosal smooth muscle cells treated with polyinosinic acid: polycytidylic acid. Inter-α- trypsin inhibitor is crucial to structure and function, The American Journal of Pathology, vol. 163, no. 1, pp. 121133, 2003.
11. S. Kessler, H. Rho, G. West, C. Fiocchi, J. Drazba, and C. de laMotte, "Hyaluronan (HA) deposition precedes and promotes leukocyte recruitment in intestinal inflammation," Clinical and Translational Science, vol. 1, no. 1, pp. 57-61, 2008.
12. D. R. Hill, H. K. Rho, S. P. Kessler et al., "Humanmilk hyaluronan enhances innate defense of the intestinal epithelium," The Journal of Biological Chemistry, vol. 288, no. 40, pp. 29090-29104, 2013.
13. C. De La Motte, J. Nigro, A. Vasanji et al., "Plateletderived hyaluronidase 2 cleaves hyaluronan into fragments that trigger monocyte-mediated production of proinflammatory cytokines," The American Journal of Pathology, vol. 174, no. 6, pp. 2254-2264, 2009.
14. H. Harada and M. Takahashi, "CD44-dependent intracellular and extracellular catabolism of hyaluronic acid by hyaluronidase-1 and -2," The Journal of Biological Chemistry, vol. 282, no. 8, pp. 5597-5607, 2007.
15. H. Yoshida, A. Nagaoka, S. Nakamura, Y. Sugiyama, Y. Okada, and S. Inoue, "Murine homologue of the human KIAA1199 is implicated in hyaluronan binding and depolymerization," FEBS Open Bio, vol. 3, pp. 352-356, 2013.
16. A. K. Majors, R. C. Austin, C. A. de La Motte et al., "Endoplasmic reticulum stress induces hyaluronan deposition and leukocyte adhesion," The Journal of Biological Chemistry, vol. 278, no. 47, pp. 47223-47231, 2003.
17. C. A. de LaMotte, V. C. Hascall, A. Calabro, B. Yen-Lieberman, and S. A. Strong, "Mononuclear leukocytes preferentially bind via CD44 to hyaluronan on human intestinal mucosal smooth muscle cells after virus infection or treatment with poly(I?C)," The Journal of Biological Chemistry, vol. 274, no. 43, pp. 30747-30755, 1999.
18. F. Rieder, S. Kessler, M. Sans, and C. Fiocchi, "Animal models of intestinal fibrosis: new tools for the understand ing of pathogenesis and therapy of human disease," The American Journal of Physiology-Gastrointestinal and Liver Physiology, vol. 303, no. 7, pp. G786-G801, 2012.
19. K. J. Bai, A. P. Spicer, M. M. Mascarenhas et al., "The role of hyaluronan synthase 3 in ventilator-induced lung injury," The American Journal of Respiratory and Critical Care Medicine, vol. 172, no. 1, pp. 92-98, 2005.
20. N. Kobayashi, S. Miyoshi, T. Mikami et al., "Hyaluronan deficiency in tumor stroma impairsmacrophage trafficking and tumor neovascularization," Cancer Research, vol. 70, no. 18, pp. 7073-7083, 2010.
21. S. N. S. Murthy, H. S. Cooper, H. Shim, R. S. Shah, S. A. Ibrahim, and D. J. Sedergran, "Treatment of dextran sulfate sodiuminduced murine colitis by intracolonic cyclosporin," Digestive Diseases and Sciences, vol. 38, no. 9, pp. 1722-1734, 1993.
22. M. Mähler, I. J. Bristol, E. H. Leiter et al., "Differential susceptibility of inbred mouse strains to dextran sulfate sodiuminduced colitis," American Journal of Physiology-Gastrointestinal and Liver Physiology, vol. 274, no. 3, pp. G544-G551, 1998.
23. E. J. Shin, M. J. Sung, H. J. Yang, M. S. Kim, and J.-T. Hwang, "Boehmeria nivea attenuates the development of dextran sulfate sodium-induced experimental colitis," Mediators of Inflammation, vol. 2014, Article ID 231942, 7 pages, 2014.
24. C. A. de la Motte and J. A. Drazba, "Viewing hyaluronan: imaging contributes to imagining new roles for this amazing matrix polymer," Journal of Histochemistry and Cytochemistry, vol. 59, no. 3, pp. 252-257, 2011.
25. I. Okayasu, S. Hatakeyama, M. Yamada, T. Ohkusa, Y. Inagaki, and R. Nakaya, "A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice," Gastroenterology, vol. 98, no. 3, pp. 694-702, 1990.
26. M. Allocca, M. Jovani, G. Fiorino, S. Schreiber, and S. Danese, "Anti-IL-6 treatment for inflammatory bowel diseases: next cytokine, next target," Current Ddrug Targets, vol. 14, no. 12, pp. 1508-1521, 2013.
27. S. L. S. Yan, J. Russell, and D. N. Granger, "Platelet activationand platelet-leukocyte aggregation elicited in experimental colitis are mediated by interleukin-6," Inflammatory Bowel Diseases, vol. 20, no. 2, pp. 353-362, 2014.
28. R. Stern, "Hyaluronan catabolism: a new metabolic pathway," European Journal of Cell Biology, vol. 83, no. 7, pp. 317-325, 2004.
29. S. Adamia, A. A. Reichert, H. Kuppusamy et al., "Inherited and acquired variations in the hyaluronan synthase 1 (HAS1) gene may contribute to disease progression inmultiplemyeloma and Waldenstrom macroglobulinemia," Blood, vol. 112, no. 13, pp. 5111-5121, 2008.
30. A.-E. Declèves, N. Caron, V. Voisin et al., "Synthesis and fragmentation of hyaluronan in renal ischaemia," Nephrology Dialysis Transplantation, vol. 27, no. 10, pp. 3771-3781, 2012.
31. P. Moffatt, E. R. Lee, B. St-Jacques, K. Matsumoto, Y. Yamaguchi, and P. J. Roughley, "Hyaluronan production by means of Has2 gene expression in chondrocytes is essential for long bone development," Developmental Dynamics, vol. 240, no. 2, pp. 404-412, 2011.
32. P. J. Roughley, L. Lamplugh, E. R. Lee, K. Matsumoto, and Y. Yamaguchi, "The role of hyaluronan produced by Has2 gene expression in development of the spine," Spine, vol. 36, no. 14, pp. E914-E920, 2011.
33. X. Zhu, X. Deng, G. Huang et al., "A novelmutation ofHyaluronan synthase 2 gene in Chinese children with ventricular septal defect," PLoS ONE, vol. 9, no. 2, Article ID e87437, 2014.
34. D. C. Martin, V. Atmuri, R. J. Hemming et al., "A mouse model of human mucopolysaccharidosis IX exhibits osteoarthritis," Human Molecular Genetics, vol. 17, pp. 1904-1915, 2008.
35. B. Triggs-Raine, T. J. Salo, H. Zhang, B. A. Wicklow, and M. R. Natowicz, "Mutations in HYAL1, a member of a tand emly distributed multigene family encoding disparate hyaluronidase activities, cause a newly described lysosomal disorder, mucopolysaccharidosis IX," Proceedings of the National Academy of Sciences of the United States of America, vol. 96, no. 11, pp. 6296-6300, 1999.
36. B. Chowdhury, R. Hemming, S. Hombach-Klonisch, B. Flamion, and B. Triggs-Raine, "Murine hyaluronidase 2 deficiency results in extracellular hyaluronan accumulation and severe cardiopulmonary dysfunction," The Journal of Biological Chemistry, vol. 288, no. 1, pp. 520-528, 2013.
37. L. Jadin, X. Wu, H. Ding et al., "Skeletal and hematological anomalies in HYAL2-deficient mice: a second type of mucopolysaccharidosis IX?" FASEB Journal, vol. 22, no. 12, pp. 4316-4326, 2008.
38. R.-X. Zhang, J.-H. Zhu, J. Fan, and X.-Q. Ji, "Analysis of HYAL3 gene mutations in Chinese lung squamous cell carcinoma patients," Tumori, vol. 99, no. 1, pp. 108-112, 2013.
39. A. Jacobson, J. Brinck, M. J. Briskin, A. P. Spicer, and P. Heldin, "Expression of human hyaluronan syntheses in response to external stimuli," The Biochemical Journal, vol. 348, no. 1, pp. 29-35, 2000.
40. A. D. Recklies, C. White, L. Melching, and P. J. Roughley, "Differential regulation and expression of hyaluronan synthases in human articular chondrocytes, synovial cells and osteosarcoma cells," The Biochemical Journal, vol. 354, no. 1, pp. 17-24, 2001.
41. L. Zheng, T. E. Riehl, and W. F. Stenson, "Regulation of colonic epithelial repair in mice by Toll-like receptors and hyaluronic acid," Gastroenterology, vol. 137, no. 6, pp. 2041-2051, 2009.
42. F. Rieder, L. Cheng, K. M. Harnett et al., "Gastroesophageal reflux disease-associated esophagitis induces endogenous cytokine production leading to motor abnormalities," Gastroenterology, vol. 132, no. 1, pp. 154-165, 2007.
43. S. A. Strong, T. T. Pizarro, J. S. Klein, F. Cominelli, and C. Fiocchi, "Proinflammatory cytokines differentially modulate their own expression in human intestinal mucosal mesenchymal cells," Gastroenterology, vol. 114, no. 6, pp. 1244-1256, 1998.
44. N. Itano, T. Sawai, M. Yoshida et al., "Three isoforms of mammalian hyaluronan synthases have distinct enzymatic properties," The Journal of Biological Chemistry, vol. 274, no. 35, pp. 25085-25092, 1999.
45. K. A. Scheibner, M. A. Lutz, S. Boodoo, M. J. Fenton, J. D. Powell, and M. R. Horton, "Hyaluronan fragments act as an endogenous danger signal by engaging TLR2," Journal of Immunology, vol. 177, no. 2, pp. 1272-1281, 2006.
46. R. Stern, A. A. Asari, and K. N. Sugahara, "Hyaluronan fragments: an information-rich system," European Journal of Cell Biology, vol. 85, no. 8, pp. 699-715, 2006.
47. K. R. Taylor, K. Yamasaki, K. A. Radek et al., "Recognition of hyaluronan released in sterile injury involves a unique receptor complex dependent on toll-like receptor 4, CD44, and MD-2," The Journal of Biological Chemistry, vol. 282, no. 25, pp. 18265-18275, 2007.
48. J. Brinck and P. Heldin, "Expression of recombinant hyaluronan synthase (HAS) isoforms in CHO cells reduces cell migration and cell surface CD44," Experimental Cell Research, vol. 252, no. 2, pp. 342-351, 1999.
49. S. Albeiroti, K. Ayasoufi, D. R. Hill, B. Shen, and C. A. de la Motte, "Platelet hyaluronidase-2: an enzyme that translocates to the surface upon activation to function in extracellular matrix degradation," Blood, 2014.
50. A. Ghosh, H. Kuppusamy, and L. M. Pilarski, "Aberrant splice variants of HAS1 (hyaluronan synthase 1) multimerize with and modulate normally splicedHAS1 protein," The Journal of Biological Chemistry, vol. 284, no. 28, pp. 18840-18850, 2009.
51. E. Karousou, M. Kamiryo, S. S. Skandalis et al., "The activity of hyaluronan synthase 2 is regulated by dimerization and ubiquitination," The Journal of Biological Chemistry, vol. 285, no. 31, pp. 23647-23654, 2010.
52. I. Guerra and F. Bermejo, "Management of inflammatory bowel disease in poor responders to infliximab," Clinical and Experimental Gastroenterology, vol. 7, pp. 359-367, 2014.
53. Y. Sakurai, H. Hatakeyama, Y. Sato et al., "RNAi-mediated gene knockdown and anti-angiogenic therapy of RCCs using a cyclic RGD-modified liposomal-siRNA system," Journal of Controlled Release, vol. 173, no. 1, pp. 110-118, 2014.
54. Z. Huang, L. Dong, J. Chen et al., "Low-molecular weight chitosan/vascular endothelial growth factor short hairpin RNA for the treatment of hepatocellular carcinoma," Life Sciences, vol. 91, no. 23-24, pp. 1207-1215, 2012.